← Browse by Condition
Medical Condition
secondary central nervous system lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05351593 Phase 1, Phase 2
Recruiting
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Enrollment
35 pts
Location
United States
Sponsor
James Rubenstein
NCT05256641 Phase 1, Phase 2
Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...